Apollon Formularies (AQSE:APOL) Beta : -0.20 (As of May. 16, 2024)

Apollon Formularies Beta Chart

Apollon Formularies Annual Data
	Trend	Jun10	Jun11	Dec12	Dec13	Dec14	Dec17	Dec18	Dec19	Dec20	Dec21
Beta		Get a 7-Day Free Trial					-	-	-	-	-

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Beta	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Beta distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Beta falls into.

Apollon Formularies Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Apollon Formularies  (AQSE:APOL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Apollon Formularies Beta Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description